High-Purity Lonafarnib (CAS 193275-84-2) for Advanced Pharmaceutical Research
Discover Lonafarnib, a critical farnesyl transferase inhibitor, expertly supplied by a leading manufacturer in China. Ideal for R&D in oncology and rare diseases, ensuring consistent quality and reliable procurement for your laboratory needs.
Get a Quote & SamplePremium Lonafarnib: Your Trusted Supplier for Research Excellence
Lonafarnib (CAS 193275-84-2)
As a dedicated manufacturer and supplier of pharmaceutical intermediates, we offer high-quality Lonafarnib (CAS 193275-84-2). This potent farnesyl transferase inhibitor is essential for researchers investigating cancer pathways and genetic disorders like progeria. Trust us, your reliable supplier in China, for consistent purity and timely delivery to support your critical research and development projects.
- Research-Grade Lonafarnib: Sourced and supplied with stringent quality control for reliable experimental outcomes.
- Key Pharmaceutical Intermediate: Essential for developing advanced diagnostics and therapeutics.
- Expert Manufacturer in China: Benefit from direct sourcing and competitive pricing from a trusted producer.
- Strict Purity Standards: Guaranteed purity of ≥99% for critical pharmaceutical applications.
Advantages of Sourcing Lonafarnib from Us
Uncompromised Purity and Quality
Our commitment to quality ensures that every batch of Lonafarnib (CAS 193275-84-2) meets rigorous standards, providing researchers with the purity they need for accurate studies in cancer and progeria research.
Reliable Supply Chain Management
As a direct manufacturer and supplier in China, we offer a stable and dependable supply of Lonafarnib, crucial for maintaining the continuity of your research projects. Secure your supply today to avoid disruptions.
Cost-Effective Procurement
Leverage our position as a leading producer to purchase Lonafarnib (CAS 193275-84-2) at competitive prices. We provide transparent pricing and welcome inquiries for bulk purchases or custom synthesis needs.
Key Applications for Lonafarnib (CAS 193275-84-2)
Cancer Research & Therapeutics
Lonafarnib is a vital compound for exploring novel anticancer therapies, particularly its role as a farnesyl transferase inhibitor in targeting Ras protein pathways.
Progeria and Rare Disease Studies
Investigate the potential of Lonafarnib in treating rare genetic disorders like Hutchinson-Gilford progeria syndrome, where farnesyl transferase inhibition shows promise.
Pharmaceutical Intermediate Synthesis
Utilize Lonafarnib as a key intermediate in the synthesis of complex pharmaceutical compounds, contributing to the development of new drugs and diagnostic agents.
Biochemical Research Tool
Employ Lonafarnib in biochemical assays and cellular studies to understand farnesylation processes and their impact on cellular signaling and disease mechanisms.